BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18819027)

  • 1. Is it too soon for mesenchymal stem cell trials in people with ALS?
    Badayan I; Cudkowicz ME
    Amyotroph Lateral Scler; 2008 Dec; 9(6):321-2. PubMed ID: 18819027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel cell transplantation protocol and its application to an ALS mouse model.
    Morita E; Watanabe Y; Ishimoto M; Nakano T; Kitayama M; Yasui K; Fukada Y; Doi K; Karunaratne A; Murrell WG; Sutharsan R; Mackay-Sim A; Hata Y; Nakashima K
    Exp Neurol; 2008 Oct; 213(2):431-8. PubMed ID: 18691571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell treatment in Amyotrophic Lateral Sclerosis.
    Mazzini L; Mareschi K; Ferrero I; Vassallo E; Oliveri G; Nasuelli N; Oggioni GD; Testa L; Fagioli F
    J Neurol Sci; 2008 Feb; 265(1-2):78-83. PubMed ID: 17582439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of mesenchymal stem cells in ALS.
    Mazzini L; Vercelli A; Ferrero I; Boido M; Cantello R; Fagioli F
    Prog Brain Res; 2012; 201():333-59. PubMed ID: 23186722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cell therapy in amyotrophic lateral sclerosis: science and controversy].
    Galán L; Guerrero-Sola A; Gómez-Pinedo U; Matias-Guiu J
    Neurologia; 2010 Oct; 25(8):467-9. PubMed ID: 20964996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot study of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood stem cells in amyotrophic lateral sclerosis (ALS).
    Cashman N; Tan LY; Krieger C; Mädler B; Mackay A; Mackenzie I; Benny B; Nantel S; Fabros M; Shinobu L; Yousefi M; Eisen A
    Muscle Nerve; 2008 May; 37(5):620-5. PubMed ID: 18335482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in stem cell research for Amyotrophic Lateral Sclerosis.
    Papadeas ST; Maragakis NJ
    Curr Opin Biotechnol; 2009 Oct; 20(5):545-51. PubMed ID: 19819686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential use of adult stem cells for the treatment of multiple sclerosis and other neurodegenerative disorders.
    Slavin S; Kurkalli BG; Karussis D
    Clin Neurol Neurosurg; 2008 Nov; 110(9):943-6. PubMed ID: 18325660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.
    O'Connor DM; Boulis NM
    Neurosci Lett; 2012 Oct; 527(2):78-84. PubMed ID: 22579818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis: signals for hope?
    Allers C; Jones JA; Lasala GP; Minguell JJ
    Regen Med; 2014; 9(5):637-47. PubMed ID: 25372079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis.
    Appel SH; Engelhardt JI; Henkel JS; Siklos L; Beers DR; Yen AA; Simpson EP; Luo Y; Carrum G; Heslop HE; Brenner MK; Popat U
    Neurology; 2008 Oct; 71(17):1326-34. PubMed ID: 18936424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up.
    Deda H; Inci MC; Kürekçi AE; Sav A; Kayihan K; Ozgün E; Ustünsoy GE; Kocabay S
    Cytotherapy; 2009; 11(1):18-25. PubMed ID: 19012065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.
    Petrou P; Gothelf Y; Argov Z; Gotkine M; Levy YS; Kassis I; Vaknin-Dembinsky A; Ben-Hur T; Offen D; Abramsky O; Melamed E; Karussis D
    JAMA Neurol; 2016 Mar; 73(3):337-44. PubMed ID: 26751635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone marrow stem cell transplantation in amyotrophic lateral sclerosis: technical aspects and preliminary results from a clinical trial].
    Blanquer M; Pérez Espejo MA; Iniesta F; Gómez Espuch J; Meca J; Villaverde R; Izura V; de Mingo P; Martínez-Lage J; Martínez S; Moraleda JM
    Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():31-7. PubMed ID: 21381286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compassionate use of stem cells for ALS: popovers and hot air.
    Bedlack RS
    Amyotroph Lateral Scler; 2011 Sep; 12(5):313-4. PubMed ID: 21554029
    [No Abstract]   [Full Text] [Related]  

  • 16. Mesenchymal stem cells for ALS patients.
    Mazzini L; Vercelli A; Mareschi K; Ferrero I; Testa L; Fagioli F
    Amyotroph Lateral Scler; 2009 Apr; 10(2):123-4. PubMed ID: 19085190
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cellular therapy in amyotrophic lateral sclerosis].
    Matías-Guiu J; Barcia JA; García-Verdugo JM; Galán L; Vela A; García-Ramos R
    Neurologia; 2008 May; 23(4):226-37. PubMed ID: 18307053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of stem cell therapies in amyotrophic lateral sclerosis.
    Srivastava AK
    Neurol India; 2014; 62(3):239-48. PubMed ID: 25033844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell transplantation into the intraventricular space via an Ommaya reservoir in a patient with amyotrophic lateral sclerosis.
    Baek W; Kim YS; Koh SH; Lim SW; Kim HY; Yi HJ; Kim H
    J Neurosurg Sci; 2012 Sep; 56(3):261-3. PubMed ID: 22854595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALS combination treatment. Drug cocktails.
    Rosenfeld J
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():115-7. PubMed ID: 15512890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.